Jijun Xu, MD, PhD

Ph.D. in Neuroscience and Genes & Development; Opioid tolerance, Graduate School of Biomedical Sciences (GSBS), The University of Texas Health Science Center at Houston, The University of Texas (UT) M.D. Anderson Cancer Center, Houston, TX 2002-2007

Postdoctoral Fellow, Inflammatory and Neuropathic Pain, Department of Anesthesiology and Pain Medicine, UT MD Anderson Cancer Center, TX 2007-2009

• 2023 Review Editor, Frontiers in Human Neuroscience – Sensory Neuroscience
• 2021 Merit of Distinction Abstract, American Academy of Neurology (AAN)
• 2020 Best of the Meeting Award, the 19th Annual meeting, American Society of Regional Anesthesia and Pain Medicine (ASRA)
• 2020 Best Pain Abstract, Congress of Neurological Surgeons (CNS)
• 2020 “Best Teacher” and “Cleveland Clinic Pain Medicine Staff of the Year”
• 2020 NIH NCI grant “Complement in Chemotherapy-induced Peripheral Neuropathy”
• 2020 NIH Study section panel “Somatosensory and Pain System”
• 2016 “Best Teacher” and “Cleveland Clinic Pain Medicine Staff of the Year”

See publications for this provider. (Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists collaborate with industry to advance medical breakthroughs. These partnerships help commercialize discoveries for public benefit while maintaining scientific integrity. To ensure transparency and minimize potential bias, Cleveland Clinic reviews these relationships and publicly discloses when physicians/scientists receive significant compensation for consulting, serve in fiduciary roles, receive royalties, or hold equity interests related to their work. We manage potential conflicts through approval processes, annual reporting, and targeted management plans.

As of 2025-07-09, Dr. Xu has reported the financial relationships with the companies listed below.

Donation of Financial Interest. Dr. Xu has consulted for, received compensation for serving as a fiduciary from, or received royalties from the following companies but instructed them to donate all compensation to not-for-profit causes or to the Cleveland Clinic to support research and education:

• New Cloud Medical

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.